Plain-English translation of NCT05976490 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new support program called NeuroPathways designed specifically for people who have recently been diagnosed with a malignant brain tumor. The program includes an information guide and four one-on-one counseling sessions with a healthcare professional like a nurse or counselor. The researchers want to see whether this program helps patients cope better with their diagnosis and improve their emotional well-being.
A brain tumor diagnosis is overwhelming, and patients often struggle to understand what comes next and how to manage the emotional impact. This trial exists to see if having a structured, personalized support program can better help patients process their diagnosis and develop coping skills during this difficult time.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive an information guide about living with a brain tumor diagnosis and meet with a counselor for four individual sessions over several weeks. You'll also be asked to complete brief surveys at the start, after 8 weeks, and after 12 weeks to help researchers understand how you're doing. Some participants may also be asked to share feedback about the program in an exit interview.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States